Cite
A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma.
MLA
Lv, Jiali, et al. “A Serum Metabolomics Analysis Reveals a Panel of Screening Metabolic Biomarkers for Esophageal Squamous Cell Carcinoma.” Clinical & Translational Medicine, vol. 11, no. 5, May 2021, pp. 1–6. EBSCOhost, https://doi.org/10.1002/ctm2.419.
APA
Lv, J., Wang, J., Shen, X., Liu, J., Zhao, D., Wei, M., Li, X., Fan, B., Sun, Y., Xue, F., Zhu, Z., & Zhang, T. (2021). A serum metabolomics analysis reveals a panel of screening metabolic biomarkers for esophageal squamous cell carcinoma. Clinical & Translational Medicine, 11(5), 1–6. https://doi.org/10.1002/ctm2.419
Chicago
Lv, Jiali, Jialin Wang, Xiaotao Shen, Jia Liu, Deli Zhao, Mengke Wei, Xia Li, et al. 2021. “A Serum Metabolomics Analysis Reveals a Panel of Screening Metabolic Biomarkers for Esophageal Squamous Cell Carcinoma.” Clinical & Translational Medicine 11 (5): 1–6. doi:10.1002/ctm2.419.